Cargando…

High-cited favorable studies for COVID-19 treatments ineffective in large trials

OBJECTIVES: To evaluate for coronavirus disease 2019 treatments without benefits in subsequent large randomized controlled trials (RCTs) how many of their most-cited clinical studies had declared favorable results. STUDY DESIGN AND SETTING: Scopus searches (December 23, 2021) identified articles on...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ioannidis, John P.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Covid-19 Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986133/ https://www.ncbi.nlm.nih.gov/pubmed/35398190 http://dx.doi.org/10.1016/j.jclinepi.2022.04.001

Ejemplares similares

Favorable outcome of COVID-19 infection in a patient with congenital myasthenic syndrome
por: Bonanno, Silvia, et al.
Publicado: (2021)

How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework
por: Sharma, Tanmay, et al.
Publicado: (2022)

COVID-19 Living Overview of Evidence repository is highly comprehensive and can be used as a single source for COVID-19 studies
por: Verdugo-Paiva, Francisca, et al.
Publicado: (2022)

Toward an observatory of the evolution of clinical trials through phylomemy reconstruction: the COVID-19 vaccines example
por: Lobbé, Quentin, et al.
Publicado: (2022)

The relationship between pragmatism, timing, and study size on impact of randomized trials: a qualitative, hypothesis generating study of trials of systemic corticosteroids for COVID-19
por: Liang, Aileen, et al.
Publicado: (2022)

Understanding how deferred consent affects patient characteristics and outcomes: an exploratory analysis of a clinical trial of prone positioning for COVID-19
por: Colacci, Michael, et al.
Publicado: (2023)

COVID-19 and the research scholarship ecosystem: help!
por: Moher, David
Publicado: (2021)

The currency and completeness of specialized databases of COVID-19 publications
por: Butcher, Robyn, et al.
Publicado: (2022)

A framework for identifying and mitigating the equity harms of COVID-19 policy interventions
por: Glover, Rebecca E., et al.
Publicado: (2020)

A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation map
por: Pottie, Kevin, et al.
Publicado: (2022)

A case study in model failure? COVID-19 daily deaths and ICU bed utilisation predictions in New York state
por: Chin, Vincent, et al.
Publicado: (2020)

Three out of four published systematic reviews on COVID-19 treatments were not registered and one-third of those registered were published: a meta-research study
por: Siemens, Waldemar, et al.
Publicado: (2022)

Evidence, values, and masks for control of COVID-19: 2 years later
por: Djulbegovic, Benjamin, et al.
Publicado: (2022)

Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
por: Devogelaere, Jens, et al.
Publicado: (2020)

Noninterventional studies in the COVID-19 era: methodological considerations for study design and analysis
por: Butler, Anne M., et al.
Publicado: (2023)

Artificial intelligence in COVID-19 evidence syntheses was underutilized, but impactful: a methodological study
por: Tercero-Hidalgo, Juan R., et al.
Publicado: (2022)

An evaluation of the COVID-19 recommendation map identified diverging clinical and public health guidance
por: Nasir, Zil H., et al.
Publicado: (2022)

Weekly updates of national living evidence-based guidelines: methods for the Australian living guidelines for care of people with COVID-19
por: Tendal, Britta, et al.
Publicado: (2021)

Weekly updating of guideline recommendations was feasible: the Australian National COVID-19 clinical evidence Taskforce
por: Hewitt, Jessie, et al.
Publicado: (2023)

COVID-19 antibody seroprevalence in Santa Clara County, California
por: Bendavid, Eran, et al.
Publicado: (2021)

HIV suppression was maintained during the COVID-19 pandemic in Malawi: a program-level cohort study
por: Kalua, Thokozani, et al.
Publicado: (2022)

Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies
por: Lin, Kueiyu Joshua, et al.
Publicado: (2022)

Predicting COVID-19 prognosis in the ICU remained challenging: external validation in a multinational regional cohort
por: Meijs, Daniek A.M., et al.
Publicado: (2022)

Minimal reporting improvement after peer review in reports of COVID-19 prediction models: systematic review
por: Hudda, Mohammed T., et al.
Publicado: (2023)

Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive
por: Ewers, Michael, et al.
Publicado: (2021)

Cox regression using a calendar time scale was unbiased in simulations of COVID-19 vaccine effectiveness & safety
por: Lund, Lars Christian, et al.
Publicado: (2023)

An assessment of psychological distress and professional burnout in mental health professionals in Australia during the COVID-19 pandemic
por: Northwood, K, et al.
Publicado: (2021)

Integrating travel history via big data analytics under universal healthcare framework for disease control and prevention in the COVID-19 pandemic
por: Ma, Kevin Sheng-Kai
Publicado: (2021)

Methodology and design of platform trials: a meta-epidemiological study
por: Pitre, Tyler, et al.
Publicado: (2023)

Universal COVID-19 screening at hospitals in a large Canadian health region
por: Garrod, Matthew, et al.
Publicado: (2023)

Hydrogen peroxide as an auxiliary treatment for COVID-19 in Brazil: a randomized double-blind clinical trial
por: Domênico, Marielle Bazzo Di, et al.
Publicado: (2021)

Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort
por: Caspersen, Ida Henriette, et al.
Publicado: (2022)

Molecular Epidemiology of Large COVID-19 Clusters at an Academic Medical Center, March–October 2020
por: Kobayashi, Takaaki, et al.
Publicado: (2021)

The vulnerability to COVID-19 of migrants in large urban areas: structural exacerbators and community-level mitigators
por: Hitch, Lisa, et al.
Publicado: (2023)

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
por: Cao, Yang, et al.
Publicado: (2020)

Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials
por: Siordia, Juan A., et al.
Publicado: (2020)

MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine
por: Seferoğlu, Meral, et al.
Publicado: (2021)

The Impact of COVID-19 on Cancer Risk and Treatment
por: Jyotsana, Nidhi, et al.
Publicado: (2020)

Treatment of chronic or relapsing COVID-19 in immunodeficiency
por: Brown, Li-An K., et al.
Publicado: (2022)

Lessons learnt from the first large outbreak of COVID-19 in health-care settings in Tasmania, Australia
por: Johnston, Fay H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nna5lpn1dhaogh43qierrvpifj